Evergreen Theragnostics develops theranostic solutions that integrate diagnostic technologies with targeted therapeutic strategies, aimed at enabling molecularly guided treatment selection and patient monitoring.
The company focuses on providing actionable biomarker assays and companion diagnostics to support personalized medicine workflows for clinicians and clinical researchers.
Leadership & Board
Current Number of Employees55
Current LinkedIn Followers15,189
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$26M
Total Amount Raised$26M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$26M
Latest Funding Amount$26M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Evergreen Theragnostics had 55 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
55Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Evergreen Theragnostics had 15,189 followers as of September 28, 2026. The number of followers increased by 6 (0.04%) week-over-week.
15,189Latest Followers Count
6(0.04%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.